Pricing Log in Create free account

PepGen, Inc. (PEPG) vs Sutro Biopharma, Inc. (STRO)

PepGen, Inc. and Sutro Biopharma, Inc. are both Biotechnology companies. PepGen, Inc. and Sutro Biopharma, Inc. are of similar size ($169.7M and $164.8M). PepGen, Inc. has the higher net margin (0.00% vs −395.3%) and the lower return on invested capital (−2,076.3% vs 0.00%). Across the 12 metrics below, PepGen, Inc. leads on 8 and Sutro Biopharma, Inc. on 4.

Valuation

Metric PEPG STRO Biotechnology median
P/E n/m n/m 10.26
P/S n/m 3.34 9.18
P/B 1.34 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.03 0.65
EV/Sales n/m (0.08) 8.98
Earnings yield (56.71%) (187.89%) (34.89%)
Free cash flow yield (43.48%) (95.31%) (24.52%)

Profitability

Metric PEPG STRO Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (319.57%) 0.00%
Net margin 0.00% (395.25%) 0.00%
Free cash flow margin 0.00% (318.63%) 0.00%
Return on equity (75.45%) 266.76% (50.12%)
Return on assets (59.06%) (79.08%) (45.60%)
Return on invested capital (2,076.25%) 0.00% 0.00%

Growth

Metric PEPG STRO Biotechnology median
Revenue growth (TTM) — (56.25%) 6.26%
EPS growth (last fiscal year) 25.61% 24.02% 29.88%
Revenue growth, 5-year CAGR — 19.12% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PEPG STRO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.36 3.32 4.89
Net debt to EBITDA 1.64 0.92 1.01

Dividend

Metric PEPG STRO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PEPG STRO Biotechnology median
Market cap 169.69m 164.82m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack